Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The Nuclear Receptor CAR Is a Regulator of Thyroid Hormone Metabolism during Caloric Restriction*
Jodi M. Maglich,
Joe Watson,
Patrick J. McMillen¶,
Bryan Goodwin,
Timothy M. Willson||, , and
John T. Moore**
High Throughput Biology, Bioscience Support, ¶Genetics Research, and ||High Throughput Chemistry, GlaxoSmithKline, Research Triangle Park, North Carolina 27709
Abstract:
The orphan nuclear receptor CAR (NR1I3) has been characterizedas a central component in the coordinate response to xenobioticand endobiotic stress. In this study, we demonstrate that CARplays a pivotal function in energy homeostasis and establishan unanticipated metabolic role for this nuclear receptor. Wild-typemice treated with the synthetic CAR agonist 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene(TCPOBOP) exhibited decreased serum concentration of the thyroidhormone (TH) thyroxine (T4). However, treatment of Car/mice with TCPOBOP failed to elicit these changes. To examinewhether CAR played a role in the regulation of TH levels underphysiological conditions, wild-type and Car/ micewere fasted for 24 h, a process known to alter TH metabolismin mammals. As expected, the serum triiodothyronine and T4 concentrationsdecreased in wild-type mice. However, triiodothyronine and T4levels in fasted Car/ mice remained significantlyhigher than those in fasted wild-type animals. Concomitant withthe changes in serum TH levels, both CAR agonist treatment andfasting induced the expression of CAR target genes (notably,Cyp2b10, Ugt1a1, Sultn, Sult1a1, and Sult2a1) in a receptor-dependentmanner. Importantly, the Ugt1a1, Sultn, Sult1a1, and Sult2a1genes encode enzymes that are capable of metabolizing TH. Anattenuated reduction in TH levels during fasting, as observedin Car/ mice, would be predicted to increase weightloss during caloric restriction. Indeed, when Car/animals were placed on a 40% caloric restriction diet for 12weeks, Car/ animals lost over twice as much weightas their wild-type littermates. Thus, CAR participates in themolecular mechanisms contributing to homeostatic resistanceto weight loss. These data imply that CAR represents a noveltherapeutic target to uncouple metabolic rate from food intakeand has implications in obesity and its associated disorders.
Received for publication December 11, 2003.
Revision received February 27, 2004.
* The costs of publication of this article were defrayed in partby the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: GlaxoSmithKline, 5 Moore Dr., Venture116-1b, Research Triangle Park, NC 27709. Tel.: 919-483-3936; Fax: 919-315-6720; E-mail: John.T.Moore{at}gsk.com.
The editors suggest the following Related Resources on Science sites:
Regulation of Hepatic Phase II Metabolism in Pregnant Mice.
X. Wen, A. C. Donepudi, P. E. Thomas, A. L. Slitt, R. S. King, and L. M. Aleksunes (2013)
J. Pharmacol. Exp. Ther.
344, 244-252
|Abstract »|Full Text »|PDF »
Effect of Tight Glucose Control with Insulin on the Thyroid Axis of Critically Ill Children and Its Relation with Outcome.
M. Gielen, D. Mesotten, P. J. Wouters, L. Desmet, D. Vlasselaers, I. Vanhorebeek, L. Langouche, and G. Van den Berghe (2012)
J. Clin. Endocrinol. Metab.
97, 3569-3576
|Abstract »|Full Text »|PDF »
Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21.
H. A. Cyphert, X. Ge, A. B. Kohan, L. M. Salati, Y. Zhang, and F. B. Hillgartner (2012)
J. Biol. Chem.
287, 25123-25138
|Abstract »|Full Text »|PDF »
Contribution of Nutritional Deficit to the Pathogenesis of the Nonthyroidal Illness Syndrome in Critical Illness: A Rabbit Model Study.
L. Mebis, A. Eerdekens, F. Guiza, L. Princen, S. Derde, Y.-M. Vanwijngaerden, I. Vanhorebeek, V. M. Darras, G. Van den Berghe, and L. Langouche (2012)
Endocrinology
153, 973-984
|Abstract »|Full Text »|PDF »
Multi-species Analyses of Direct Activators of the Constitutive Androstane Receptor.
C. J. Omiecinski, D. M. Coslo, T. Chen, E. M. Laurenzana, and R. C. Peffer (2011)
Toxicol. Sci.
123, 550-562
|Abstract »|Full Text »|PDF »
Xenobiotic Metabolism, Disposition, and Regulation by Receptors: From Biochemical Phenomenon to Predictors of Major Toxicities.
C. J. Omiecinski, J. P. Vanden Heuvel, G. H. Perdew, and J. M. Peters (2011)
Toxicol. Sci.
120, S49-S75
|Abstract »|Full Text »|PDF »
Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy Metabolism.
A Functional Cross-Talk between Liver X Receptor-{alpha} and Constitutive Androstane Receptor Links Lipogenesis and Xenobiotic Responses.
Y. Zhai, T. Wada, B. Zhang, S. Khadem, S. Ren, R. Kuruba, S. Li, and W. Xie (2010)
Mol. Pharmacol.
78, 666-674
|Abstract »|Full Text »|PDF »
Energy Restriction Does Not Compensate for the Reduced Expression of Hepatic Drug-Processing Genes in Mice with Aging.
Y.-K. J. Zhang, K. W. Saupe, and C. D. Klaassen (2010)
Drug Metab. Dispos.
38, 1122-1131
|Abstract »|Full Text »|PDF »
A Single Amino Acid Controls the Functional Switch of Human Constitutive Androstane Receptor (CAR) 1 to the Xenobiotic-Sensitive Splicing Variant CAR3.
T. Chen, L. M. Tompkins, L. Li, H. Li, G. Kim, Y. Zheng, and H. Wang (2010)
J. Pharmacol. Exp. Ther.
332, 106-115
|Abstract »|Full Text »|PDF »
Thyroid Hormone Is Necessary for Expression of Constitutive Androstane Receptor in Rat Hepatocytes.
H. Ooe, J. Kon, H. Oshima, and T. Mitaka (2009)
Drug Metab. Dispos.
37, 1963-1969
|Abstract »|Full Text »|PDF »
Octachlorostyrene Induces Cytochrome P450, UDP-glucuronosyltransferase, and Sulfotransferase via the Aryl Hydrocarbon Receptor and Constitutive Androstane Receptor.
Y. Yanagiba, Y. Ito, M. Kamijima, F. J. Gonzalez, and T. Nakajima (2009)
Toxicol. Sci.
111, 19-26
|Abstract »|Full Text »|PDF »
Molecular characterization of SMILE as a novel corepressor of nuclear receptors.
Y.-B. Xie, B. Nedumaran, and H.-S. Choi (2009)
Nucleic Acids Res.
37, 4100-4115
|Abstract »|Full Text »|PDF »
Di(2-ethylhexyl) phthalate Is a Highly Potent Agonist for the Human Constitutive Androstane Receptor Splice Variant CAR2.
J. G. DeKeyser, M. C. Stagliano, S. S. Auerbach, K. S. Prabhu, A. D. Jones, and C. J. Omiecinski (2009)
Mol. Pharmacol.
75, 1005-1013
|Abstract »|Full Text »|PDF »
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification.
The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress.
J. M. Maglich, D. C. Lobe, and J. T. Moore (2009)
J. Lipid Res.
50, 439-445
|Abstract »|Full Text »|PDF »
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling.
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco (2008)
Endocr. Rev.
29, 898-938
|Abstract »|Full Text »|PDF »
The Peripheral Benzodiazepine Receptor Ligand 1-(2-Chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide Is a Novel Antagonist of Human Constitutive Androstane Receptor.
L. Li, T. Chen, J. D. Stanton, T. Sueyoshi, M. Negishi, and H. Wang (2008)
Mol. Pharmacol.
74, 443-453
|Abstract »|Full Text »|PDF »
Ghrelin secretion is not reduced by increased fat mass during diet-induced obesity.
X. Qi, J. T. Reed, G. Wang, S. Han, E. W. Englander, and G. H. Greeley Jr. (2008)
Am J Physiol Regulatory Integrative Comp Physiol
295, R429-R435
|Abstract »|Full Text »|PDF »
Low replacement doses of thyroxine during food restriction restores type 1 deiodinase activity in rats and promotes body protein loss.
R. L. Araujo, B. M. de Andrade, A. S. P. de Figueiredo, M. L. da Silva, M. P. Marassi, V. dos Santos Pereira, E. Bouskela, and D. P Carvalho (2008)
J. Endocrinol.
198, 119-125
|Abstract »|Full Text »|PDF »
Calorie restriction and cardiometabolic health.
L. Fontana (2008)
European Journal of Cardiovascular Prevention & Rehabilitation
15, 3-9
|Abstract »|Full Text »|PDF »
Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice.
Y. Alnouti and C. D. Klaassen (2008)
J. Pharmacol. Exp. Ther.
324, 612-621
|Abstract »|Full Text »|PDF »
The Xenobiotic-Sensing Nuclear Receptors Pregnane X Receptor, Constitutive Androstane Receptor, and Orphan Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha} in the Regulation of Human Steroid-/Bile Acid-Sulfotransferase.
I. Echchgadda, C. S. Song, T. Oh, M. Ahmed, I. J. De La Cruz, and B. Chatterjee (2007)
Mol. Endocrinol.
21, 2099-2111
|Abstract »|Full Text »|PDF »
C. Chen, X. Cheng, M. Z. Dieter, Y. Tanaka, and C. D. Klaassen (2007)
Mol. Pharmacol.
71, 1159-1164
|Abstract »|Full Text »|PDF »
CAR2 Displays Unique Ligand Binding and RXR{alpha} Heterodimerization Characteristics.
S. S. Auerbach, J. G. DeKeyser, M. A. Stoner, and C. J. Omiecinski (2007)
Drug Metab. Dispos.
35, 428-439
|Abstract »|Full Text »|PDF »
In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase.
S. M. Blattler, F. Rencurel, M. R. Kaufmann, and U. A. Meyer (2007)
PNAS
104, 1045-1050
|Abstract »|Full Text »|PDF »
Activation of Pregnane X Receptor Disrupts Glucocorticoid and Mineralocorticoid Homeostasis.
Y. Zhai, H. V. Pai, J. Zhou, J. A. Amico, R. R. Vollmer, and W. Xie (2007)
Mol. Endocrinol.
21, 138-147
|Abstract »|Full Text »|PDF »
The Nuclear Receptor Constitutively Active/Androstane Receptor Regulates Type 1 Deiodinase and Thyroid Hormone Activity in the Regenerating Mouse Liver.
E. S. Tien, K. Matsui, R. Moore, and M. Negishi (2007)
J. Pharmacol. Exp. Ther.
320, 307-313
|Abstract »|Full Text »|PDF »
Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver.
F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet, and U. A. Meyer (2006)
Mol. Pharmacol.
70, 1925-1934
|Abstract »|Full Text »|PDF »
Regulation of Constitutive Androstane Receptor and Its Target Genes by Fasting, cAMP, Hepatocyte Nuclear Factor {alpha}, and the Coactivator Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha}.
X. Ding, K. Lichti, I. Kim, F. J. Gonzalez, and J. L. Staudinger (2006)
J. Biol. Chem.
281, 26540-26551
|Abstract »|Full Text »|PDF »
Effect of Long-Term Calorie Restriction with Adequate Protein and Micronutrients on Thyroid Hormones.
L. Fontana, S. Klein, J. O. Holloszy, and B. N. Premachandra (2006)
J. Clin. Endocrinol. Metab.
91, 3232-3235
|Abstract »|Full Text »|PDF »
Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor.
S. R. Faucette, T. Sueyoshi, C. M. Smith, M. Negishi, E. L. LeCluyse, and H. Wang (2006)
J. Pharmacol. Exp. Ther.
317, 1200-1209
|Abstract »|Full Text »|PDF »
Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1{alpha}.
J. Miao, S. Fang, Y. Bae, and J. K. Kemper (2006)
J. Biol. Chem.
281, 14537-14546
|Abstract »|Full Text »|PDF »
Indirect Regulation of Human Dehydroepiandrosterone Sulfotransferase Family 1A Member 2 by Thyroid Hormones.
Induction of Type 3 Deiodinase Activity in Inflammatory Cells of Mice with Chronic Local Inflammation.
A. Boelen, J. Kwakkel, A. Alkemade, R. Renckens, E. Kaptein, G. Kuiper, W. M. Wiersinga, and T. J. Visser (2005)
Endocrinology
146, 5128-5134
|Abstract »|Full Text »|PDF »
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity.
J. C. Corton and H. M. Brown-Borg (2005)
J Gerontol A Biol Sci Med Sci
60, 1494-1509
|Abstract »|Full Text »|PDF »
Retinoid X Receptor-{alpha}-Dependent Transactivation by a Naturally Occurring Structural Variant of Human Constitutive Androstane Receptor (NR1I3).
S. S. Auerbach, M. A. Stoner, S. Su, and C. J. Omiecinski (2005)
Mol. Pharmacol.
68, 1239-1253
|Abstract »|Full Text »|PDF »
The Ratio of Constitutive Androstane Receptor to Pregnane X Receptor Determines the Activity of Guggulsterone against the Cyp2b10 Promoter.
Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors.
J. C. Corton, U. Apte, S. P. Anderson, P. Limaye, L. Yoon, J. Latendresse, C. Dunn, J. I. Everitt, K. A. Voss, C. Swanson, et al. (2004)
J. Biol. Chem.
279, 46204-46212
|Abstract »|Full Text »|PDF »
Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
M. S. Kim, J. Shigenaga, A. Moser, C. Grunfeld, and K. R. Feingold (2004)
Am J Physiol Endocrinol Metab
287, E731-E738
|Abstract »|Full Text »|PDF »